New Frontier Minerals Limited

NFM

Castillo Copper Ltd. engages in the business of mineral exploration and examination of new resource opportunities which focuses on copper, cobalt, and rare earth elements projects in Australia and Zambia. The company is headquartered in Perth, Western Australia. The company went IPO on 2010-12-14. The firm is focused on developing multicommodity assets. Its primary focus is on advancing exploration activity at its wholly owned NWQ Project, located in the copper-belt district over 150 kilometers (km) north of Mt Isa in north-west Queensland. The NWQ Copper Project comprises five mineral leases, covering a total area of 977 square kilometers (km2). Its other interests include the Broken Hill Project in western New South Wales and the Cangai Copper Mine in north-east New South Wales, as well as exploration targets in Zambia. The Broken Hill East Project consists of two tenements covering over 684.3 km2 (EL8434 and EL8435). Cangai Copper Project consists of three exploration tenures: EL 8625, EL 8635 and EL 8601. The company also has an 85% interest in the highly prospective Harts Range Niobium, Uranium and Heavy Rare Earths Project, circa 120km north-east from Alice Springs in the Northern Territory (NT).

Netlinkz Limited

NET

NetLinkz Ltd. provides a flexible, efficient, secure and cost-effective Software-Defined Wide Area Network solution connecting any site to any device, anywhere, on any network with ease. The firm delivers a cloud-based cyber-secure invisible network-as-a-service (NaaS) for enterprise customers. The company is also a global reseller for Starlink satellite Internet services. Its NaaS proposition is user-centric, creating a per-user private network that is available, secure and performance optimized, for authorized users regardless of their location. The company offers a range of products across three categories: Secure Internet, with Netlinkz transforming Starlink technology into a business grade service providing secure Internet and an invisible cloud network; Network Security, which future proofs clients’ business with Netlinkz’s cloud first private work solutions, and Secure CCTV and IoT, with Netlinkz ensuring that all clients’ video feeds and data from their CCTV and IoT systems are transferred, integrity checked and securely stored. Its products include Starlink FIXED, Starlink FREEDOM and Starlink MARITIME.

Neuren Pharmaceuticals Limited

NEU

Neuren Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment, and neurodegenerative disorders. The company is headquartered in Melbourne, Victoria. The company went IPO on 2005-02-03. The firm is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. The Company’s product DAYBUE (trofinetide) is used to treat Rett syndrome in adults and pediatric patients two years of age and older. The United States (US) Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both granted orphan drug designation to the Company for trofinetide in Fragile X syndrome. Its second product NNZ-2591 is in phase II clinical trials in Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome. The firm has granted an exclusive worldwide license to Acadia Pharmaceuticals Inc. for the development and commercialization of NNZ-259 for Rett syndrome and Fragile X syndrome.